{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:23:13Z","timestamp":1773876193759,"version":"3.50.1"},"reference-count":47,"publisher":"Japan Neurosurgical Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol. Med. Chir.(Tokyo)"],"published-print":{"date-parts":[[2025,2,15]]},"DOI":"10.2176\/jns-nmc.2024-0066","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T22:11:32Z","timestamp":1735078292000},"page":"61-70","source":"Crossref","is-referenced-by-count":4,"title":["Development of Machine-learning Model to Predict Anticoagulant Use and Type in Geriatric Traumatic Brain Injury Using Coagulation Parameters"],"prefix":"10.2176","volume":"65","author":[{"given":"Gaku","family":"FUJIWARA","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Saiseikai Shiga Hospital, Imperial Gift Foundation Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"OKADA","sequence":"additional","affiliation":[{"name":"Department of Preventive Services, School of Public Health, Kyoto University"},{"name":"Health Services and Systems Research, Duke-NUS Medical School, National University of Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"SUEHIRO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, International University of Health and Welfare School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"YATSUSHIGE","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Hospital Organization Disaster Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"HIROTA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tsuchiura Kyodo General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"HASEGAWA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kumamoto Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"KARIBE","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Sendai City Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"MIYATA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Chiba Emergency Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenya","family":"KAWAKITA","sequence":"additional","affiliation":[{"name":"Emergency Medical Center, Kagawa University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"HAJI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Yamaguchi University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"AIHARA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hyogo Prefectural Kakogawa Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"YOKOBORI","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoki","family":"INAJI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Institute of Science Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"MAEDA","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Nihon University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"ONUKI","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Teikyo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"OSHIO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, St. Marianna University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobukazu","family":"KOMORIBAYASHI","sequence":"additional","affiliation":[{"name":"Iwate Prefectural Advanced Critical Care and Emergency Center, Iwate Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiyasu","family":"SUZUKI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Yamaguchi University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"SHIOMI","sequence":"additional","affiliation":[{"name":"Department of Critical and Intensive Care Medicine, Shiga University of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Dossett LA, Riesel JN, Griffin MR, Cotton BA: Prevalence and implications of preinjury warfarin use: an analysis of the National Trauma Databank. <i>Arch Surg<\/i> 2011: 146: 565-570","DOI":"10.1001\/archsurg.2010.313"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Brewer ES, Reznikov B, Liberman RF, et al.: Incidence and predictors of intracranial hemorrhage after minor head trauma in patients taking anticoagulant and antiplatelet medication. <i>J Trauma<\/i> 2011: 70: E1-E5","DOI":"10.1097\/TA.0b013e3181e5e286"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Pieracci FM, Eachempati SR, Shou J, Hydo LJ, Barie PS: Use of long-term anticoagulation is associated with traumatic intracranial hemorrhage and subsequent mortality in elderly patients hospitalized after falls: analysis of the New York State Administrative Database. <i>J Trauma<\/i> 2007: 63: 519-524","DOI":"10.1097\/TA.0b013e31812e519b"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) McMillian WD, Rogers FB: Management of prehospital antiplatelet and anticoagulant therapy in traumatic head injury: a review. <i>J Trauma<\/i> 2009: 66: 942-950","DOI":"10.1097\/TA.0b013e3181978e7b"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Fujiwara G, Okada Y, Shiomi N, Sakakibara T, Yamaki T, Hashimoto N: Derivation of coagulation phenotypes and the association with prognosis in traumatic brain injury: a cluster analysis of Nationwide Multicenter Study. <i>Neurocrit Care<\/i> 2024: 40: 292-302","DOI":"10.1007\/s12028-023-01712-6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Sigal A, Butts CA, Deaner T, et al.: Potentially inappropriate medications are associated with geriatric trauma recidivism. <i>J Surg Res<\/i> 2023: 283: 581-585","DOI":"10.1016\/j.jss.2022.10.029"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kato ET, Goto S, Giugliano RP: Overview of oral antithrombotic treatment in elderly patients with atrial fibrillation. <i>Ageing Res Rev<\/i> 2019: 49: 115-124","DOI":"10.1016\/j.arr.2018.10.006"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Goldstein JN, Refaai MA, Milling TJ, et al.: Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. <i>Lancet<\/i> 2015: 385: 2077-2087","DOI":"10.1016\/S0140-6736(14)61685-8"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Connolly SJ, Crowther M, Eikelboom JW, et al.: Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. <i>N Engl J Med<\/i> 2019: 380: 1326-1335","DOI":"10.1056\/NEJMoa1814051"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Pollack CV, Reilly PA, van Ryn J, et al.: Idarucizumab for Dabigatran Reversal - full cohort analysis. <i>N Engl J Med<\/i> 2017: 377: 431-441","DOI":"10.1056\/NEJMoa1707278"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Verschoof MA, Zuurbier CCM, de Beer F, Coutinho JM, Eggink EA, van Geel BM: Evaluation of the yield of 24-h close observation in patients with mild traumatic brain injury on anticoagulation therapy: a retrospective multicenter study and meta-analysis. <i>J Neurol<\/i> 2018: 265: 315-321","DOI":"10.1007\/s00415-017-8701-y"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Carpenter E, Singh D, Dietrich E, Gums J: Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulation. <i>Ther Adv Drug Saf<\/i> 10: 2042098619888133, 2019","DOI":"10.1177\/2042098619888133"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Adcock DM, Gosselin RC: The danger of relying on the APTT and PT in patients on DOAC therapy, a potential patient safety issue. <i>Int J Lab Hematol<\/i> 2017: 39: 37-40","DOI":"10.1111\/ijlh.12658"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Samuelson BT, Cuker A, Siegal DM, Crowther M, Garcia DA: Laboratory assessment of the anticoagulant activity of direct oral anticoagulants: a systematic review. <i>Chest<\/i> 2017: 151: 127-138","DOI":"10.1016\/j.chest.2016.08.1462"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Nakae R, Takayama Y, Kuwamoto K, Naoe Y, Sato H, Yokota H: Time course of coagulation and fibrinolytic parameters in patients with traumatic brain injury. <i>J Neurotrauma<\/i> 2016: 33: 688-695","DOI":"10.1089\/neu.2015.4039"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Stekhoven DJ, B\u00fchlmann P: MissForest--non-parametric missing value imputation for mixed-type data. <i>Bioinformatics<\/i> 2012: 28: 112-118","DOI":"10.1093\/bioinformatics\/btr597"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Waljee AK, Mukherjee A, Singal AG, et al.: Comparison of imputation methods for missing laboratory data in medicine. <i>BMJ Open<\/i> 2013: 3: 1-7","DOI":"10.1136\/bmjopen-2013-002847"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Nakanishi Y, Tsugihashi Y, Akahane M, et al.: Comparison of Japanese centenarians&apos; and noncentenarians&apos; medical expenditures in the last year of life. <i>JAMA Netw Open<\/i> 2021: 4: 1-15","DOI":"10.1001\/jamanetworkopen.2021.31884"},{"key":"19","unstructured":"19) B\u00f6hm JK, Schaeben V, Sch\u00e4fer N, et al.: Extended coagulation profiling in isolated traumatic brain injury: a CENTER-TBI analysis. <i>Neurocrit Care<\/i> 2022: 36: 927-941"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Frans G, Meeus P, Bailleul E: Resolving DOAC interference on aPTT, PT, and lupus anticoagulant testing by the use of activated carbon. <i>J Thromb Haemost<\/i> 2019: 17: 1354-1362","DOI":"10.1111\/jth.14488"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Heo JN, Yoon JG, Park H, Kim YD, Nam HS, Heo JH: Machine learning-based model for prediction of outcomes in acute stroke. <i>Stroke<\/i> 2019: 50: 1263-1265","DOI":"10.1161\/STROKEAHA.118.024293"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Song J, Gao Y, Yin P, et al.: The random forest model has the best accuracy among the four pressure ulcer prediction models using machine learning algorithms. <i>Risk Manag Healthc Policy<\/i> 2021: 14: 1175-1187","DOI":"10.2147\/RMHP.S297838"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Hanko M, Grend\u00e1r M, Snopko P, et al.: Random forest-based prediction of outcome and mortality in patients with traumatic brain injury undergoing primary decompressive craniectomy. <i>World Neurosurg<\/i> 2021: 148: e450-e458","DOI":"10.1016\/j.wneu.2021.01.002"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Schonlau M, Zou RY: The random forest algorithm for statistical learning. <i>Stata J<\/i> 2020: 20: 3-29","DOI":"10.1177\/1536867X20909688"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Fletcher-Sandersj\u00f6\u00f6 A, Thelin EP, Maegele M, Svensson M, Bellander BM: Time course of hemostatic disruptions after traumatic brain injury: a systematic review of the literature. <i>Neurocrit Care<\/i> 2021: 34: 635-656","DOI":"10.1007\/s12028-020-01037-8"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Nakae R, Fujiki Y, Takayama Y, et al.: Age-related differences in the time course of coagulation and fibrinolytic parameters in patients with traumatic brain injury. <i>Int J Mol Sci<\/i> 2020: 21: 1-14","DOI":"10.3390\/ijms21165613"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Halpern CH, Reilly PM, Turtz AR, Stein SC: Traumatic coagulopathy: the effect of brain injury. <i>J Neurotrauma<\/i> 2008: 25: 997-1001","DOI":"10.1089\/neu.2008.0548"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Moore EE, Moore HB, Kornblith LZ, et al.: Trauma-induced coagulopathy. <i>Nat Rev Dis Primers<\/i> 2021: 7: 30","DOI":"10.1038\/s41572-021-00264-3"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Kumano O, Akatsuchi K, Amiral J: Updates on anticoagulation and laboratory tools for therapy monitoring of heparin, vitamin k antagonists and direct oral anticoagulants. <i>Biomedicines<\/i> 2021: 9: 264","DOI":"10.3390\/biomedicines9030264"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Miyamoto S, Ogasawara K, Kuroda S, et al.: Japan Stroke Society Guideline 2021 for the treatment of stroke. <i>Int J Stroke<\/i> 2022: 17: 1039-1049","DOI":"10.1177\/17474930221090347"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Mulliez SMN, Van Den Bogaert J, Devreese KMJ: Influence of vitamin K antagonist treatment on activated partial thromboplastin time. <i>Clin Chem Lab Med<\/i> 2015: 53: e47-e50","DOI":"10.1515\/cclm-2014-0688"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Chornenki NLJ, Fralick M, Sholzberg M: International normalized ratio and activated partial thromboplastin time testing. <i>CMAJ<\/i> 2022: 194: E1135","DOI":"10.1503\/cmaj.220629"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Kearon C, Johnston M, Moffat K, McGinnis J, Ginsberg JS: Effect of warfarin on activated partial thromboplastin time in patients receiving heparin. <i>Arch Intern Med<\/i> 1998: 158: 1140-1143","DOI":"10.1001\/archinte.158.10.1140"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Kovacevic MP, Lupi KE, Wong A, Gilmore JF, Malloy R: Evaluation of the effect of apixaban on INR in the inpatient population. <i>J Cardiovasc Pharmacol Ther<\/i> 2019: 24: 355-358","DOI":"10.1177\/1074248419838502"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Wang X, Tirucherai G, Marbury TC, et al.: Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis. <i>J Clin Pharmacol<\/i> 2016: 56: 628-636","DOI":"10.1002\/jcph.628"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Tripodi A, Padovan L, Testa S, et al.: How the direct oral anticoagulant apixaban affects hemostatic parameters. Results of a multicenter multiplatform study. <i>Clin Chem Lab Med<\/i> 2015: 53: 265-273","DOI":"10.1515\/cclm-2014-0531"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) McRae HL, Militello L, Refaai MA: Updates in anticoagulation therapy monitoring. <i>Biomedicines<\/i> 2021: 9: 262","DOI":"10.3390\/biomedicines9030262"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Wiegele M, Sch\u00f6chl H, Haushofer A, et al.: Diagnostic and therapeutic approach in adult patients with traumatic brain injury receiving oral anticoagulant therapy: an Austrian interdisciplinary consensus statement. <i>Crit Care<\/i> 2019: 23: 1-16","DOI":"10.1186\/s13054-019-2352-6"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Marsch A, Macha K, Siedler G, et al.: Direct oral anticoagulant plasma levels for the management of acute ischemic stroke. <i>Cerebrovasc Dis<\/i> 2019: 48: 17-25","DOI":"10.1159\/000502335"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Cuker A: Laboratory measurement of the non-vitamin K antagonist oral anticoagulants: selecting the optimal assay based on drug, assay availability, and clinical indication. <i>J Thromb Thrombolysis<\/i> 2016: 41: 241-247","DOI":"10.1007\/s11239-015-1282-7"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Drouet L, Bal dit Sollier C, Steiner T, Purrucker J: Measuring non-vitamin K antagonist oral anticoagulant levels: when is it appropriate and which methods should be used? <i>Int J Stroke<\/i> 2016: 11: 748-758","DOI":"10.1177\/1747493016659671"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Dunois C: Laboratory monitoring of direct oral anticoagulants (DOACs). <i>Biomedicines<\/i> 2021: 9: 445","DOI":"10.3390\/biomedicines9050445"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) van Ryn J, Stangier J, Haertter S, et al.: Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. <i>Thromb Haemost<\/i> 2010: 103: 1116-1127","DOI":"10.1160\/TH09-11-0758"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Mani H: Interpretation of coagulation test results under direct oral anticoagulants. <i>Int J Lab Hematol<\/i> 2014: 36: 261-268","DOI":"10.1111\/ijlh.12235"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Ofek F, Bar Chaim S, Kronenfeld N, Ziv-Baran T, Berkovitch M: International normalized ratio is significantly elevated with rivaroxaban and apixaban drug therapies: a retrospective study. <i>Clin Ther<\/i> 2017: 39: 1003-1010","DOI":"10.1016\/j.clinthera.2017.04.007"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Lip GYH, Keshishian A, Kang A, et al.: Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy. <i>Eur Heart J Cardiovasc Pharmacother<\/i> 2021: 7: 405-414","DOI":"10.1093\/ehjcvp\/pvaa117"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Powers AY, Pinto MB, Tang OY, Chen JS, Doberstein C, Asaad WF: Predicting mortality in traumatic intracranial hemorrhage. <i>J Neurosurg<\/i> 2019: 132: 552-559","DOI":"10.3171\/2018.11.JNS182199"}],"container-title":["Neurologia medico-chirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/65\/2\/65_2024-0066\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T04:30:54Z","timestamp":1739593854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/65\/2\/65_2024-0066\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2024-0066","relation":{},"ISSN":["0470-8105","1349-8029"],"issn-type":[{"value":"0470-8105","type":"print"},{"value":"1349-8029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"article-number":"2024-0066"}}